be_ixf;ym_202605 d_14; ct_50

Latest Insights on ABBV

Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]
This Biotech Billionaire Loves This Risky Stock April 11, 2018 by Brian Christopher Technology, Trending There is a chance you will lose money if you buy today’s stock. But if you’re willing to take on a little risk, I have an opportunity for you that could be very profitable.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

Share This